TY  - JOUR 
AU  - Salamero, Olga
AU  - Martínez-Cuadrón, David
AU  - Sobas, Marta
AU  - Benavente, Celina
AU  - Susana, Vives
AU  - de la Serna, Javier
AU  - Pérez Encinas, Manuel Mateo
AU  - Escoda, Lourdes
AU  - Gil, Cristina
AU  - Brunet, Salut
AU  - Ramos, Fernando
AU  - Esteve, Jordi
AU  - Amigo, Mariluz
AU  - Krsnik, Isabel
AU  - Manso, Félix
AU  - Arias Sampedro, Jesús
AU  - González-Campos, José
AU  - Serrano, Josefina
AU  - Oleksiuk, Jalanta
AU  - Barrios, Manuel
AU  - García-Boyero, Raimundo
AU  - Novo, Andrés
AU  - Sanz, Miguel A.
AU  - Montesinos, Pau
PY  - 2019
UR  - http://hdl.handle.net/20.500.11940/22421
AB  - [EN] Acute promyelocytic leukemia is infrequent among patients aged ≥75 years old, a population that is rarely eligible for clinical protocols. This study aims to analyze the treatment strategies and clinical outcomes of very old APL patients reported...
LA  - eng
KW  - Aged
KW  - Treatment Outcome
KW  - Follow-Up Studies
KW  - Humans
KW  - Cohort Studies
KW  - Remission Induction
KW  - Leukemia, Promyelocytic, Acute
KW  - Registries
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Survival Rate
KW  - Tretinoin
TI  - Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry
DO  - 10.1080/10428194.2019.1607327
T2  - Leukemia & Lymphoma
M2  - 2720
KW  - CHUS
KW  - CHULA
VL  - 60
ER  -